October 1, 2014 – Toronto, Ontario – Matica Enterprises Inc. (CSE: GRF) (“Matica” or the “Company”) reports on the successful Annual General and Special Meeting (“AGSM”) which was held on September 29, 2014 in Toronto, Ontario. At the AGSM, the Company’s shareholders re-elected the following directors to the board: David Lee, Charn Deol and Boris Ziger. The Company’s shareholders also elected Rawn Lakhan to the board as a new director. Mr. Lakhan was previously on the advisory board to the Company. The Company also reappointed the current officers: Boris Ziger – CEO and Richard Tong – CFO.
At the AGSM, the Company’s shareholders also passed a resolution, by simple majority, approving the Company’s change of business from mineral exploration to medical marijuana. This was an important step in Matica’s transformation. Further to the Company’s change of business, Matica’s board of directors will be creating a special committee to address the Company’s existing mineral property assets so that the Company’s management can remain focussed on Matica’s core business of medical marijuana.
ABOUT MATICA ENTERPRISES INC.
Matica has an exclusive agreement to market FTI Foodtech International Inc.’s chlorine dioxide tablets for use as a natural cleaning and sanitizing product for growing medical marijuana. Matica is further exploring opportunities in the medical marijuana and industrial hemp industries. Matica has graphite projects in Buckingham, Quebec and in the state of Nevada. For more information on Matica Enterprises please visit the website at: www.westislandbrands.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger, CEO & Chairman
The Company’s filings are available for review at www.sedar.com and www.thecse.com.
For further information, please contact Boris Ziger, Chief Executive Officer, at:
Cautionary Note Regarding Forward-Looking Statements
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with the Canadian Securities Regulators, which filings are available at www.sedar.com and www.thecse.com.